Monthly Archives: February 2017

http://www.lslog.com/az-bounces-back-with-diabetes-combo-win-but-can-it-keep-up-with-lilly-and-bi/AZ bounces back with diabetes combo win, but can it keep up with Lilly and BI?

AZ bounces back with diabetes combo win, but can it keep up with Lilly and BI?

AZ bounces back with diabetes combo win, but can it keep up with Lilly and BI? AZ bounces back with diabetes combo win, but can it keep up with Lilly […]

http://www.lslog.com/struggling-endo-takes-3-5b-body-blow-as-generics-pricing-heads-south/Struggling Endo takes $3.5B body blow as generics pricing heads south

Struggling Endo takes $3.5B body blow as generics pricing heads south

Struggling Endo takes .5B body blow as generics pricing heads south Struggling Endo takes $3.5B body blow as generics pricing heads south chelfand Tue, 02/28/2017 – 11:05 Source: Fierce […]

http://www.lslog.com/single-digit-price-hike-pledge-jj-has-that-covered-already-company-report-says/Single-digit price-hike pledge? J&J has that covered already, company report says

Single-digit price-hike pledge? J&J has that covered already, company report says

Single-digit price-hike pledge? J&J has that covered already, company report says Single-digit price-hike pledge? J&J has that covered already, company report says esagonowsky Mon, 02/27/2017 – 16:18 Source: Fierce […]

http://www.lslog.com/prosecutors-rope-pfizer-into-fast-growing-copay-assistance-probe/Prosecutors rope Pfizer into fast-growing copay assistance probe

Prosecutors rope Pfizer into fast-growing copay assistance probe

Prosecutors rope Pfizer into fast-growing copay assistance probe Prosecutors rope Pfizer into fast-growing copay assistance probe esagonowsky Mon, 02/27/2017 – 11:15 Source: Fierce Pharma Prosecutors rope Pfizer into fast-growing […]

http://www.lslog.com/mercks-letermovir-aces-bone-marrow-transplant-study-cutting-death-rate/Merck's letermovir aces bone marrow transplant study, cutting death rate

Merck's letermovir aces bone marrow transplant study, cutting death rate

Merck’s letermovir aces bone marrow transplant study, cutting death rate Merck’s letermovir aces bone marrow transplant study, cutting death rate phil Mon, 02/27/2017 – 08:27 Source: FierceMedicalDevices News Merck’s […]

http://www.lslog.com/advaxis-pens-backloaded-358m-cancer-delivery-tech-deal/Advaxis pens backloaded $358M cancer delivery tech deal

Advaxis pens backloaded $358M cancer delivery tech deal

Advaxis pens backloaded 8M cancer delivery tech deal Advaxis pens backloaded $358M cancer delivery tech deal nick.paul.taylor Mon, 02/27/2017 – 07:59 Source: FierceMedicalDevices News Advaxis pens backloaded 8M cancer […]

http://www.lslog.com/former-valeant-philidor-execs-plead-not-guilty-to-multimillion-dollar-fraud-and-kickback-charges/Former Valeant, Philidor execs plead not guilty to multimillion-dollar fraud and kickback charges

Former Valeant, Philidor execs plead not guilty to multimillion-dollar fraud and kickback charges

Former Valeant, Philidor execs plead not guilty to multimillion-dollar fraud and kickback charges Former Valeant, Philidor execs plead not guilty to multimillion-dollar fraud and kickback charges chelfand Fri, 02/24/2017 – […]

http://www.lslog.com/ties-to-gilead-abbvie-and-bms-raise-questions-about-hep-c-drug-value-studies/Ties to Gilead, AbbVie and BMS raise questions about hep C drug value studies

Ties to Gilead, AbbVie and BMS raise questions about hep C drug value studies

Ties to Gilead, AbbVie and BMS raise questions about hep C drug value studies Ties to Gilead, AbbVie and BMS raise questions about hep C drug value studies esagonowsky Fri, […]

http://www.lslog.com/delay-to-hep-c-drug-program-behind-mercks-write-down-decision-say-analysts/Delay to hep C drug program behind Merck's write-down decision, say analysts

Delay to hep C drug program behind Merck's write-down decision, say analysts

Delay to hep C drug program behind Merck’s write-down decision, say analysts Delay to hep C drug program behind Merck’s write-down decision, say analysts phil Fri, 02/24/2017 – 08:53 […]

http://www.lslog.com/astrazenecas-fda-delayed-zs-9-gains-european-thumbs-up/AstraZeneca’s FDA delayed ZS-9 gains European thumbs-up

AstraZeneca’s FDA delayed ZS-9 gains European thumbs-up

AstraZeneca’s FDA delayed ZS-9 gains European thumbs-up AstraZeneca’s FDA delayed ZS-9 gains European thumbs-up badams Fri, 02/24/2017 – 07:33 Source: FierceMedicalDevices News AstraZeneca’s FDA delayed ZS-9 gains European thumbs-up